Clinical Trial Update: Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the PET tracer Fluoro Furanyl Norprogesterone (FFNP) to image progesterone receptor status in breast cancer. The trial status is Comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fluoro Furanyl Norprogesterone (FFNP) (Fluoro Furanyl Norprogesterone)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED